Turner Investments’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q3
Sell
-209,744
Closed -$8.81M 722
2013
Q2
$8.81M Buy
+209,744
New +$8.81M 0.12% 233